US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
US4326525A
(en)
|
1980-10-14 |
1982-04-27 |
Alza Corporation |
Osmotic device that improves delivery properties of agent in situ
|
US5364620A
(en)
|
1983-12-22 |
1994-11-15 |
Elan Corporation, Plc |
Controlled absorption diltiazem formulation for once daily administration
|
US5023252A
(en)
|
1985-12-04 |
1991-06-11 |
Conrex Pharmaceutical Corporation |
Transdermal and trans-membrane delivery of drugs
|
US5001139A
(en)
|
1987-06-12 |
1991-03-19 |
American Cyanamid Company |
Enchancers for the transdermal flux of nivadipine
|
US4992445A
(en)
|
1987-06-12 |
1991-02-12 |
American Cyanamid Co. |
Transdermal delivery of pharmaceuticals
|
US4902514A
(en)
|
1988-07-21 |
1990-02-20 |
Alza Corporation |
Dosage form for administering nilvadipine for treating cardiovascular symptoms
|
SG182849A1
(en)
|
2003-04-25 |
2012-08-30 |
Gilead Sciences Inc |
Antiviral phosphonate analogs
|
ATE505196T1
(de)
|
2004-07-27 |
2011-04-15 |
Gilead Sciences Inc |
Nukleosid phosphonat konjugate als anti hiv mittel
|
EP1852434B1
(en)
|
2005-02-21 |
2011-07-13 |
Shionogi Co., Ltd. |
Bicyclic carbamoylpyridone derivative having hiv integrase inhibiting activity
|
DK3372281T3
(da)
|
2005-04-28 |
2021-09-27 |
Viiv Healthcare Co |
Polycyklisk carbamoylpyridon-derivat med HIV-integrase-hæmmende aktivitet
|
JP2006342115A
(ja)
|
2005-06-10 |
2006-12-21 |
Shionogi & Co Ltd |
Hivインテグラーゼ阻害活性を有する多環性化合物
|
JP2009503081A
(ja)
|
2005-08-04 |
2009-01-29 |
スミスクライン ビーチャム コーポレーション |
Hivインテグラーゼ阻害薬
|
BRPI0617842A2
(pt)
|
2005-10-27 |
2011-08-09 |
Shionogi & Co |
composto ou um sal farmaceuticamente aceitável ou um solvato do mesmo, e, composição farmacêutica
|
JP2009513640A
(ja)
|
2005-10-27 |
2009-04-02 |
メルク エンド カムパニー インコーポレーテッド |
Hivインテグラーゼインヒビター
|
TW200811153A
(en)
|
2006-06-23 |
2008-03-01 |
Japan Tobacco Inc |
6-(heterocyclyl-substituted benzyl)-4-oxoquinoline compound and use thereof as HIV integrase inhibitor
|
CA2657287A1
(en)
|
2006-07-17 |
2008-01-24 |
Merck & Co., Inc. |
1-hydroxy naphthyridine compounds as anti-hiv agents
|
AU2007313293A1
(en)
|
2006-10-18 |
2008-04-24 |
Merck & Co., Inc. |
HIV integrase inhibitors
|
EA019259B1
(ru)
|
2007-11-16 |
2014-02-28 |
Джилид Сайенсиз, Инк. |
Ингибиторы репликации вируса иммунодефицита человека
|
WO2009088729A1
(en)
|
2008-01-08 |
2009-07-16 |
Merck & Co., Inc. |
Process for preparing n-substituted hydroxypyrimidinone carboxamides
|
US8129398B2
(en)
|
2008-03-19 |
2012-03-06 |
Bristol-Myers Squibb Company |
HIV integrase inhibitors
|
WO2009154870A1
(en)
|
2008-05-05 |
2009-12-23 |
Merck & Co., Inc. |
Hiv integrase inhibitors
|
EP2247601B1
(en)
|
2008-07-02 |
2013-04-10 |
Avexa Limited |
Thiazopyrimidinones and uses thereof
|
ES2395705T3
(es)
|
2008-07-25 |
2013-02-14 |
Glaxosmithkline Llc |
Compuestos químicos
|
KR101772610B1
(ko)
|
2008-07-25 |
2017-09-12 |
비이브 헬쓰케어 컴퍼니 |
화합물
|
WO2010011818A1
(en)
|
2008-07-25 |
2010-01-28 |
Smithkline Beecham Corporation |
Chemical compounds
|
HUE020489T4
(hu)
|
2008-07-25 |
2016-01-28 |
Viiv Healthcare Co |
Dolutegravir elõvegyületek
|
WO2010011815A1
(en)
|
2008-07-25 |
2010-01-28 |
Smithkline Beecham Corporation |
Chemical compounds
|
WO2010011819A1
(en)
|
2008-07-25 |
2010-01-28 |
Smithkline Beecham Corporation |
Chemical compounds
|
AU2009302663B2
(en)
|
2008-10-06 |
2012-11-08 |
Merck Sharp & Dohme Corp. |
HIV integrase inhibitors
|
ES2467108T3
(es)
|
2008-12-09 |
2014-06-11 |
Gilead Sciences, Inc. |
Moduladores de receptores tipo toll
|
JP5086478B2
(ja)
|
2008-12-11 |
2012-11-28 |
塩野義製薬株式会社 |
カルバモイルピリドンhivインテグラーゼ阻害剤及びそれらの中間体の合成
|
CA2750045A1
(en)
|
2009-01-28 |
2010-08-05 |
Merck Sharp & Dohme Corp. |
Bridged compounds as hiv integrase inhibitors
|
US8338441B2
(en)
|
2009-05-15 |
2012-12-25 |
Gilead Sciences, Inc. |
Inhibitors of human immunodeficiency virus replication
|
CN102803260B
(zh)
|
2009-06-15 |
2016-02-10 |
盐野义制药株式会社 |
被取代的多环性氨基甲酰基吡啶酮衍生物
|
WO2011011483A1
(en)
|
2009-07-22 |
2011-01-27 |
Glaxosmithkline Llc |
Chemical compounds
|
WO2011025683A1
(en)
|
2009-08-26 |
2011-03-03 |
Merck Sharp & Dohme Corp. |
Hiv integrase inhibitors
|
JP5624148B2
(ja)
|
2009-10-13 |
2014-11-12 |
エランコ・アニマル・ヘルス・アイルランド・リミテッド |
大環状インテグラーゼ阻害剤
|
HUE026849T2
(en)
|
2010-01-27 |
2016-08-29 |
Viiv Healthcare Company Corp Service Company |
Therapeutic combination containing dolutegravir, abacavir and lamivudine
|
KR20120130185A
(ko)
|
2010-02-26 |
2012-11-29 |
니뽄 다바코 산교 가부시키가이샤 |
1,3,4,8―테트라히드로―2H―피리도[1,2―a]피라진 유도체 및 그의 HIV 인테그라제 저해제로서의 이용
|
CN102958935B
(zh)
|
2010-04-02 |
2015-12-09 |
爱尔兰詹森科学公司 |
大环整合酶抑制剂
|
WO2011129095A1
(ja)
|
2010-04-12 |
2011-10-20 |
塩野義製薬株式会社 |
インテグラーゼ阻害活性を有するピリドン誘導体
|
US20130165489A1
(en)
|
2010-05-03 |
2013-06-27 |
The Trustees Of The University Of Pennsylvania |
Small Molecule Modulators of HIV-1 Capsid Stability and Methods Thereof
|
BR112013000043A2
(pt)
|
2010-07-02 |
2019-09-24 |
Gilead Sciences Inc |
derivados de ácido naft-2-ilacético para tratar aids
|
MX2012015293A
(es)
|
2010-07-02 |
2013-05-30 |
Gilead Sciences Inc |
Derivados de acido 2-quinolinil-acetico como compuestos antivirales.
|
US20140011995A1
(en)
|
2010-08-05 |
2014-01-09 |
Yukihito Sumino |
Process for Preparing Compound Having HIV Integrase Inhibitory Activity
|
TWI577377B
(zh)
|
2010-09-16 |
2017-04-11 |
Viiv醫療保健公司 |
醫藥組合物
|
EP2632454A1
(en)
|
2010-10-29 |
2013-09-04 |
Merck Sharp & Dohme Corp. |
Hiv integrase inhibitors
|
US8835411B2
(en)
|
2010-12-10 |
2014-09-16 |
Bristol-Myers Squibb Company |
HIV integrase inhibitors
|
ES2707997T3
(es)
|
2011-04-21 |
2019-04-08 |
Gilead Sciences Inc |
Compuestos de benzotiazol y su uso farmacéutico
|
PT2729448E
(pt)
|
2011-07-06 |
2015-12-02 |
Gilead Sciences Inc |
Compostos para o tratamento de vih
|
CN102863512B
(zh)
|
2011-07-07 |
2016-04-20 |
上海泓博智源医药技术有限公司 |
抗病毒化合物
|
CA2851218A1
(en)
|
2011-10-12 |
2013-04-18 |
Shionogi & Co., Ltd. |
Polycyclic pyridone derivative having integrase-inhibiting activity
|
JP6144698B2
(ja)
|
2011-12-20 |
2017-06-07 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Hiv複製の阻害剤としての縮合三環式化合物
|
ES2571479T3
(es)
|
2012-04-20 |
2016-05-25 |
Gilead Sciences Inc |
Derivados del ácido benzotiazol-6-il acético y su uso para tratar una infección por VIH
|
AU2013280828B2
(en)
|
2012-06-25 |
2017-03-09 |
Sunpower Corporation |
Brace for solar module array
|
WO2014008636A1
(en)
|
2012-07-11 |
2014-01-16 |
Merck Sharp & Dohme Corp. |
Macrocyclic compounds as hiv integrase inhibitors
|
US20150166520A1
(en)
|
2012-07-20 |
2015-06-18 |
Merck Sharp & Dohme Corp. |
Amido-substituted pyrimidinone derivatives useful for the treatment of hiv infection
|
US8906929B2
(en)
|
2012-08-16 |
2014-12-09 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
DE102012220513B4
(de)
|
2012-11-12 |
2023-02-16 |
Bayerische Motoren Werke Aktiengesellschaft |
Verfahren und Vorrichtung zur Herstellung eines Druckgussteils
|
WO2014099586A1
(en)
|
2012-12-17 |
2014-06-26 |
Merck Sharp & Dohme Corp. |
4-pyridinonetriazine derivatives as hiv integrase inhibitors
|
PT2822954E
(pt)
|
2012-12-21 |
2016-06-16 |
Gilead Sciences Inc |
Compostos carbamoilpiridona policíclicos e seu uso farmacêutico
|
EP2940019B1
(en)
|
2012-12-27 |
2018-03-28 |
Japan Tobacco Inc. |
SUBSTITUTED SPIROPYRIDO[1,2-a]PYRAZINE DERIVATIVE AND MEDICINAL USE THEREOF AS HIV INTEGRASE INHIBITOR
|
WO2014172188A2
(en)
|
2013-04-16 |
2014-10-23 |
Merck Sharp & Dohme Corp. |
4-pyridone derivative compounds and uses thereof as hiv integrase inhibitors
|
US9643982B2
(en)
|
2013-05-17 |
2017-05-09 |
Merck Sharp & Dohme Corp. |
Fused tricyclic heterocyclic compounds as HIV integrase inhibitors
|
WO2014200880A1
(en)
|
2013-06-13 |
2014-12-18 |
Merck Sharp & Dohme Corp. |
Fused tricyclic heterocyclic compounds as hiv integrase inhibitors
|
NO2865735T3
(sl)
|
2013-07-12 |
2018-07-21 |
|
|
US9421214B2
(en)
|
2013-07-12 |
2016-08-23 |
Gilead Sciences, Inc. |
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
|
WO2015039348A1
(en)
|
2013-09-23 |
2015-03-26 |
Merck Sharp & Dohme Corp. |
Tetracyclic heterocycle compounds useful as hiv integrase inhibitors
|
MA38922A3
(fr)
|
2013-09-27 |
2018-11-30 |
Merck Sharp & Dohme |
Dérivés de quinolizine substitués utiles en tant qu'inhibiteurs de l'integrase du vih
|
WO2015089847A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Spirocyclic heterocycle compounds useful as hiv integrase inhibitors
|
NO2717902T3
(sl)
|
2014-06-20 |
2018-06-23 |
|
|
EP3757105A3
(en)
|
2014-08-22 |
2021-01-06 |
Shionogi & Co., Ltd |
Polycyclic pyridone derivative having integrase inhibitory activity
|
AU2015306779B2
(en)
|
2014-08-27 |
2017-11-02 |
VIIV Healthcare UK (NO.5) Ltd |
Imidazo[1,2-a]pyridine derivatives for use as inhibitors of human immunodeficiency virus replication
|
US10150780B2
(en)
|
2014-12-09 |
2018-12-11 |
Merck Sharp & Dohme Corp. |
Spirocyclic heterocycle compounds useful as HIV integrase inhibitors
|
WO2016090545A1
(en)
|
2014-12-09 |
2016-06-16 |
Merck Sharp & Dohme Corp. |
Spirocyclic heterocycle compounds useful as hiv integrate inhibitors
|
TWI695003B
(zh)
|
2014-12-23 |
2020-06-01 |
美商基利科學股份有限公司 |
多環胺甲醯基吡啶酮化合物及其醫藥用途
|
WO2016154527A1
(en)
|
2015-03-26 |
2016-09-29 |
Merck Sharp & Dohme Corp. |
Phosphate-substituted quinolizine derivatives useful as hiv integrase inhibitors
|
US9630978B2
(en)
|
2015-04-02 |
2017-04-25 |
Gilead Sciences, Inc. |
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
|
WO2016187788A1
(en)
|
2015-05-25 |
2016-12-01 |
Merck Sharp & Dohme Corp. |
Fused tricyclic heterocyclic compounds useful for treating hiv infection
|
US10548910B2
(en)
|
2015-11-17 |
2020-02-04 |
Merck Sharp & Dohme Corp. |
Amido-substituted pyridotriazine derivatives useful as HIV integrase inhibitors
|
WO2017087256A1
(en)
|
2015-11-17 |
2017-05-26 |
Merck Sharp & Dohme Corp. |
Spirocyclic pyridotriazine derivatives useful as hiv integrase inhibitors
|
WO2017106071A1
(en)
|
2015-12-15 |
2017-06-22 |
Merck Sharp & Dohme Corp. |
Spirocyclic quinolizine derivatives useful as hiv integrase inhibitors
|
WO2017113288A1
(en)
|
2015-12-31 |
2017-07-06 |
Merck Sharp & Dohme Corp. |
Fused tricyclic heterocyclic compounds as hiv integrase inhibitors
|
US11117904B2
(en)
|
2016-06-23 |
2021-09-14 |
Viiv Healthcare Company |
Compositions and methods for the delivery of therapeutics
|
WO2018102634A1
(en)
|
2016-12-02 |
2018-06-07 |
Merck Sharp & Dohme Corp. |
Tricyclic heterocycle compounds useful as hiv integrase inhibitors
|
JOP20190130A1
(ar)
|
2016-12-02 |
2019-06-02 |
Merck Sharp & Dohme |
مركبات حلقية غير متجانسة رباعية الحلقات مفيدة كمثبطات إنزيم مدمج لفيروس نقص المناعة البشرية (hiv)
|
WO2018109786A1
(en)
|
2016-12-16 |
2018-06-21 |
Cipla Limited |
Novel polymoprphs and salts of polycyclic carbamoyl pyridone derivatives
|
WO2018140368A1
(en)
|
2017-01-26 |
2018-08-02 |
Merck Sharp & Dohme Corp. |
Substituted quinolizine derivatives useful as hiv integrase inhibitors
|
JP7065951B2
(ja)
|
2017-09-22 |
2022-05-12 |
ジュビラント エピパッド エルエルシー |
Pad阻害剤としての複素環式化合物
|
EP3752042A4
(en)
|
2018-02-13 |
2021-11-17 |
Cool Vapor Solutions |
PROCESSES AND COMPOSITIONS FOR HUMIDIFICATION AND COOLING OF GAS CURRENTS
|
EP3752144B1
(en)
|
2018-02-15 |
2022-12-28 |
Merck Sharp & Dohme LLC |
Tricyclic heterocycle compounds useful as hiv integrase inhibitors
|
EP3784241A4
(en)
|
2018-04-27 |
2022-01-19 |
Merck Sharp & Dohme Corp. |
TETRACYCLIC HETEROCYCLENIC COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS
|
CN110526930B
(zh)
|
2018-05-23 |
2022-06-03 |
莫云芬 |
抗hiv病毒的含硫多环-羟基吡啶酮甲酰胺类似物及其应用
|
WO2019232216A1
(en)
|
2018-05-31 |
2019-12-05 |
Genentech, Inc. |
Therapeutic compounds
|
EA202092923A1
(ru)
|
2018-05-31 |
2021-04-09 |
Сионоги Энд Ко., Лтд. |
Полициклическое производное пиридона
|
PE20210477A1
(es)
|
2018-05-31 |
2021-03-11 |
Shionogi & Co |
Derivado policiclico de carbamoilpiridona
|
US11884683B2
(en)
|
2018-06-05 |
2024-01-30 |
Merck Sharp & Dohme Llc |
Tricyclic heterocycle compounds useful as HIV integrase inhibitors
|
WO2019244066A2
(en)
|
2018-06-19 |
2019-12-26 |
VIIV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
WO2020003093A1
(en)
|
2018-06-25 |
2020-01-02 |
VIIV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
WO2020004443A1
(ja)
|
2018-06-27 |
2020-01-02 |
国立大学法人北海道大学 |
多環性カルバモイルピリドン誘導体を含有するアレナウイルス増殖阻害剤
|
CN116375735A
(zh)
|
2018-10-22 |
2023-07-04 |
内布拉斯加大学董事会 |
抗病毒前药及其纳米制剂
|
US20220175936A1
(en)
|
2018-11-29 |
2022-06-09 |
Board Of Regents Of The University Of Nebraska |
Antiviral prodrugs and nanoformulations thereof
|
MX2021011394A
(es)
|
2019-03-22 |
2021-10-13 |
Gilead Sciences Inc |
Compuestos de carbamoilpiridona triciclica puenteada y su uso farmaceutico.
|
WO2020221294A1
(zh)
|
2019-04-30 |
2020-11-05 |
上海拓界生物医药科技有限公司 |
桥环-3,4-二氢-吡啶并[1,2-a]吡嗪-1,8-二酮化合物及其药物用途
|
RU2717101C1
(ru)
|
2019-06-03 |
2020-03-18 |
Андрей Александрович Иващенко |
Анелированные 9-гидрокси-1,8-диоксо-1,3,4,8-тетрагидро-2Н-пиридо[1,2-a]пиразин-7-карбоксамиды - ингибиторы интегразы ВИЧ, способы их получения и применения
|
TW202120510A
(zh)
|
2019-11-13 |
2021-06-01 |
大陸商上海拓界生物醫藥科技有限公司 |
新型四環雜環化合物及其藥物用途
|
JPWO2021107065A1
(sl)
|
2019-11-28 |
2021-06-03 |
|
|
TW202133858A
(zh)
|
2019-11-28 |
2021-09-16 |
日商鹽野義製藥股份有限公司 |
以組合整合酶阻礙劑及抗hiv藥為特徵之hiv感染症的預防及治療用醫藥
|
CN115151545A
(zh)
|
2020-02-24 |
2022-10-04 |
吉利德科学公司 |
用于治疗hiv感染的四环化合物
|
KR20230079137A
(ko)
|
2020-09-30 |
2023-06-05 |
길리애드 사이언시즈, 인코포레이티드 |
가교된 트리사이클릭 카르바모일피리돈 화합물 및 이의 용도
|
FI4196479T3
(fi)
|
2021-01-19 |
2024-01-17 |
Gilead Sciences Inc |
Substituoituja pyridotriatsiiniyhdisteitä ja niiden käyttöjä
|
AR124868A1
(es)
|
2021-02-16 |
2023-05-10 |
Merck Sharp & Dohme Llc |
Compuestos de heterociclo tetracíclicos útiles como inhibidores de la integrasa del vih
|